Currently Viewing:
Supplements A Managed Care Perspective on Scientific Advances in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis: Disease State Overview
Darrell Hulisz, PharmD, RPh
Disease-Modifying Treatment of Amyotrophic Lateral Sclerosis
Jordan Schultz, PharmD, MSCS, BCACP
Currently Reading
ALS Managed Care Considerations
Briana Santaniello, PharmD, MBA
Posttest

ALS Managed Care Considerations

Briana Santaniello, PharmD, MBA
As a chronic neurological disorder characterized by the progressive deterioration of neuromuscular function, amyotrophic lateral sclerosis (ALS) renders significant physical, psychological, and emotional tolls on patients, their families, and caregivers. Coupled with and contributing to the severe impact on quality of life are the substantial economic costs, which can be direct and indirect, and personal as well as societal. Understanding the magnitude and specifics of the costs accompanying ALS will provide useful perspectives to pharmacists who treat patients with ALS.
Am J Manag Care. 2018;24:-S0

Become a Member to see the rest of this article and get access to all of our articles and resources. Membership is Free!

Register
Login
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up